Development of a Gene Therapy for Fabry Disease Using Adeno-Associated Viral Vector Mediated Gene Transfer
碩士 === 國立陽明大學 === 臨床醫學研究所 === 107 === Fabry disease (FD) is an X-linked lysosomal storage disease, which is caused by genetic mutations on human GLA gene that encoded alpha-galactosidase A enzyme. The incidence of FD was around 1 in 50,000 worldwide, but relatively higher in Taiwan at approximately...
Main Authors: | Ya-Ting Lee, 李雅婷 |
---|---|
Other Authors: | Dau-Ming Niu |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/rws3cq |
Similar Items
-
Development of Viral Tools for CNS Gene Transfer: Adeno-Associated Viral Vectors in Gene Therapy of Parkinson's Disease
by: Shevtsova, Zinayida
Published: (2006) -
A role for adeno-associated viral vectors in gene therapy
by: Renata dos Santos Coura, et al.
Published: (2008-01-01) -
Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer
by: Choi Jin-Ok, et al.
Published: (2010-04-01) -
Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
by: Yuan Qu, et al.
Published: (2019-01-01) -
Investigation and application of novel adeno-associated viral vectors for cystic fibrosis gene therapy
by: Steines, Benjamin Richard
Published: (2015)